Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,296 GBX | -0.87% | +1.54% | +16.00% |
05-27 | AstraZeneca, Daiichi Sankyo's Experimental Lung Cancer Drug Shows Improvement in Patients | DJ |
05-27 | AstraZeneca, Daiichi Sankyo’s Lung Cancer Drug Shows Mixed Results in Late-stage Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.00% | 243B | |
+38.51% | 727B | |
+31.74% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+8.44% | 205B | |
-5.97% | 203B | |
+6.19% | 164B | |
+0.31% | 164B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca : UK To Offer Alternative COVID-19 Vaccine For Under-40s On Rare Blood Clotting Concerns